VIVK is rocking the OTC world today, beginning to rally as much as 68% on volume not seen in months.
News out this morning confirms VIVK is no longer a minor league player in the biotech industry.
Management is estimating revenues of over $20 million a year! With a market cap only a fraction of that, word will spread fast across the investing world about this new player in the majors about to start hitting grand slam home runs!!
As the stem-cell research market continues to accelerate, global demand for disposable products accelerates with it, andVivakor's VivaThermic vials will become a vital, much-needed product in this industry!
Make sure you have a piece of this rookie of the year before Wall Street discovers VIVK is going to be player of the year!
Vivakor (OTCBB: VIVK) is a biotech company focused developing products that extend and/or improve your life. What a wonderful company this is that makes their money from making YOU and your loved ones live longer and healthier!!!
About Vivakor:
Vivakor, Inc. (“Vivakor,” the “Company,” or “we”) is a transdisciplinary research company that develops products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds. We also provide contract research services for third parties. We have developed numerous products and have filed many patents or provisional patents with the United States Patent and Trademark Office (USPTO). We intend to commercialize such products, after completion of any required regulatory approvals, through one of three methods: a sale of the technology, licensing of the product to a manufacturer or distributor or, in some cases, by manufacturing, marketing and directly selling the products ourselves.
No comments:
Post a Comment